2. Lam J, Polifka JE, Dohil MA. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J Am Acad Dermatol. 2008;59:295-315.
3. Tyler KH, Zirwas MJ. Pregnancy and dermatologic therapy. J Am Acad Dermatol. 2013;68:663-71.
4. Carneiro JN. Artrite psoriбsica em pacientes com psorнase: avaliaзгo de caracterнsticas clнnicas e epidemiolуgicas em um grupo de 133 pacientes brasileiros. [dissertaзгo]. Brasнlia (DF): Universidade de Brasнlia; 2011. p.96.
5. Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR. Psoriasis and pregnancy. J Cutan Med Surg. 2002;6:561-70.
6. Viktil KK, Engeland A, Furu K. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol. 2012;41:196-201.
7. Bae YS, Van Voorhees AS, Hsu S et al. Review of treatment options for psoriasis in pregnant or lactating women: From the medical Board of National Psoriasis Foundation. J Am Acad Dermatol. 2012;67:459-77.
8. Ostensen M, Forger F. How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol. 2013;13:470-5.
9. National Psoriasis Foundation. About psoriasis: statistics. [cited 2013 Nov 10]. Available from: http://www. psoarisis.org/learn_statistics.
10. Horn EJ, Chambers CD, Menter A, Kimball AB. International Psoriasis Council. Pregnancy outcomes in psoriasis: why do we know so little? J Am Acad Dermatol. 2009;61:e5-8.
11. Yang YW, Chen CS, Chen YH, Lin HC. Psoriasis and pregnancy outcomes: a nationwide population-based study. J Am Acad Dermatol. 2011;64:71-7.
12. Pariser D. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus onpercutaneous absorption. Am J Ther. 2009;16:264-73.
13. Griffiths CEM, Camp R, Barker JNWN. Psoriasis. In: Burns T BS, Cox N, Griffiths C, editors. Rook`s Textbook of Dermatology. Italy: Blackwell Science; 2004. p.35.46-35.47.
14. Rosmarin DM, Lebwohl M, Elewski BE, Gottlieb AB. National Psoriasis Foundation. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2010;62:838-53.
15. Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: an update and clinical review. Int J Dermatol. 2002;41:197-203.
16. Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.bAn Bras Dermatol 2015 (9): 367-75.
17. Griffiths CE. Management of psoriasis in pregnancy: time to deliver? Br J Dermatol. 2010;163:235.
18. Weatherhead S, Robson SC, Reynolds NJ. Management of psoriasis in pregnancy. BMJ. 2007;334:1218-20.
19. Matuszewska A, Misterska-Skуra M, Wiland P. Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy. Ann Acad Med Stetin. 2010;56:45-7.
20. Richmond S, Atkins J. A population-based study of the prenatal diagnosis of congenital malformation over 16 years. BJOG. 2005;112:1349-57.
- Abstract viewed - 240 times
- PDF BG/EN downloaded - 73 times
Department of Propedeutics of Internal Diseases Medical University – Plovdiv
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
How to Cite
PSORIASIS, PSORIATIC ARTHRITIS AND PREGNANCY: THE SAFETY OF THE LOCAL AND SYSTEMIC THERAPIES (PART ONE)
Vol 26 No 4 (2018): Focus on Osteoarthritis and Rheumatoid Arthritis
Submitted: Aug 5, 2018
Published: Dec 1, 2018
Psoriasis is a disease that affects 2-3% of the world population. 30-40% of the affected patients develop psoriatic arthritis. Almost 50% of them are women, with 75% under the age of 40 years. Treatment of psoriasis and psoriatic arthritis requires knowledge of the reproductive aspects of the disease. There are treatment-related risks that may affect pregnancy planning and pregnancy itself. Local (topical) and systemic therapies may cause damage to the mother and the fetus. Female patients with psoriatic arthritis at reproductive age pose questions that can be resolved by a specialist-rheumatologist in collaboration with other professionals.